D. Peake

1.8k total citations
23 papers, 1.2k citations indexed

About

D. Peake is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Rheumatology. According to data from OpenAlex, D. Peake has authored 23 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 13 papers in Surgery and 10 papers in Rheumatology. Recurrent topics in D. Peake's work include Sarcoma Diagnosis and Treatment (14 papers), Bone Tumor Diagnosis and Treatments (9 papers) and Bladder and Urothelial Cancer Treatments (4 papers). D. Peake is often cited by papers focused on Sarcoma Diagnosis and Treatment (14 papers), Bone Tumor Diagnosis and Treatments (9 papers) and Bladder and Urothelial Cancer Treatments (4 papers). D. Peake collaborates with scholars based in United Kingdom, Sweden and Netherlands. D. Peake's co-authors include R. J. Grimer, Beatrice Seddon, Ian Judson, D. Spooner, Craig Gerrand, Jeremy Whelan, Nick Athanasou, Bruce Morland, Syed A. Hussain and R. M. Tillman and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

D. Peake

23 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Peake United Kingdom 15 845 411 389 381 214 23 1.2k
Daniel P. Nussbaum United States 25 945 1.1× 946 2.3× 1.2k 3.1× 82 0.2× 256 1.2× 83 1.8k
Ugo Cioffi Italy 19 483 0.6× 861 2.1× 372 1.0× 283 0.7× 81 0.4× 120 1.3k
Akshay Baheti India 17 362 0.4× 323 0.8× 225 0.6× 112 0.3× 64 0.3× 90 841
P Hermanek Germany 19 1.1k 1.3× 437 1.1× 471 1.2× 433 1.1× 208 1.0× 82 2.0k
O. Schwandner Germany 31 288 0.3× 1.8k 4.5× 1.2k 3.0× 830 2.2× 120 0.6× 116 2.3k
Hae Giu Lee South Korea 16 372 0.4× 418 1.0× 98 0.3× 184 0.5× 63 0.3× 47 1.1k
Núria Laínez Spain 16 672 0.8× 432 1.1× 327 0.8× 70 0.2× 74 0.3× 77 1.1k
Cyrus A. Kotwall United States 20 467 0.6× 641 1.6× 596 1.5× 60 0.2× 171 0.8× 39 1.3k
Najla Fasih Canada 17 232 0.3× 602 1.5× 125 0.3× 148 0.4× 46 0.2× 45 1.2k
Olivier Collard France 16 1.1k 1.3× 182 0.4× 681 1.8× 440 1.2× 324 1.5× 67 1.6k

Countries citing papers authored by D. Peake

Since Specialization
Citations

This map shows the geographic impact of D. Peake's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Peake with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Peake more than expected).

Fields of papers citing papers by D. Peake

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Peake. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Peake. The network helps show where D. Peake may publish in the future.

Co-authorship network of co-authors of D. Peake

This figure shows the co-authorship network connecting the top 25 collaborators of D. Peake. A scholar is included among the top collaborators of D. Peake based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Peake. D. Peake is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gerrand, Craig, Jessica Bate, Beatrice Seddon, et al.. (2020). Seeking international consensus on approaches to primary tumour treatment in Ewing sarcoma. PubMed. 10(1). 21–21. 14 indexed citations
3.
Gerrand, Craig, Nick Athanasou, Bernadette Brennan, et al.. (2016). UK guidelines for the management of bone sarcomas. PubMed. 6(1). 7–7. 165 indexed citations
4.
Robinson, Martin, Piers Gaunt, R. J. Grimer, et al.. (2016). Vortex Trial: A Randomized Controlled Multicenter Phase 3 Trial of Volume of Postoperative Radiation Therapy Given to Adult Patients With Extremity Soft Tissue Sarcoma (STS). International Journal of Radiation Oncology*Biology*Physics. 96(2). S1–S1. 12 indexed citations
5.
Albergo, José I., Czar Louie Gaston, Minna Laitinen, et al.. (2016). Ewing’s sarcoma. The Bone & Joint Journal. 98-B(8). 1138–1144. 43 indexed citations
6.
Puls, Florian, Linda Magnusson, Hassan Douis, et al.. (2015). Non‐fibrosing sclerosing epithelioid fibrosarcoma: an unusual variant. Histopathology. 68(5). 760–763. 5 indexed citations
7.
Pakos, Emilios E., R. J. Grimer, D. Peake, et al.. (2011). The ‘other’ bone sarcomas. Journal of Bone and Joint Surgery - British Volume. 93-B(9). 1271–1278. 10 indexed citations
8.
Sumathi, Vaiyapuri P., Lars‐Gunnar Kindblom, A. Abudu, et al.. (2011). Prognostic Factors and Metastatic Patterns in Primary Myxoid/Round-Cell Liposarcoma. Sarcoma. 2011. 1–10. 80 indexed citations
9.
Grimer, R. J., Nick Athanasou, Craig Gerrand, et al.. (2010). UK Guidelines for the Management of Bone Sarcomas. Sarcoma. 2010. 1–14. 67 indexed citations
10.
Hilman, Serena, S. Sothi, D. Peake, Johanna C. Andersson‐Assarsson, & J. M. Meis. (2009). Gastrointestinal stromal tumour with aKITexon 11 mutation presenting as a paratesticular mass. British Journal of Radiology. 82(977). e98–e101. 1 indexed citations
11.
Grimer, R. J., et al.. (2008). Soft-tissue sarcomas of the hand. Journal of Bone and Joint Surgery - British Volume. 90-B(2). 209–214. 49 indexed citations
12.
Tanière, Philippe, et al.. (2008). Use of Imatinib Mesylate in Gastrointestinal Stromal Tumours: Pan-Birmingham Cancer Network Experience. Clinical Oncology. 20(7). 517–522. 10 indexed citations
13.
Walji, Nawaz, et al.. (2008). Common acute oncological emergencies: diagnosis, investigation and management. Postgraduate Medical Journal. 84(994). 418–427. 20 indexed citations
14.
Grimer, R. J., A. Abudu, D. Peake, et al.. (2006). Does the method of treatment affect the outcome in soft-tissue sarcomas of the adductor compartment?. Journal of Bone and Joint Surgery - British Volume. 88-B(11). 1480–1486. 18 indexed citations
15.
Wilson, Jayne S., Martin Connock, Fengju Song, et al.. (2005). Imatinib for the treatment of patients with unresectable and/or metastatic gastrointestinal stromal tumours: systematic review and economic evaluation. Health Technology Assessment. 9(25). 1–142. 123 indexed citations
16.
Hussain, Syed A., Deborah Stocken, D. Peake, et al.. (2004). Long-term results of a phase II study of synchronous chemoradiotherapy in advanced muscle invasive bladder cancer. British Journal of Cancer. 90(11). 2106–2111. 52 indexed citations
17.
Hussain, Syed A., Deborah Stocken, Peter Riley, et al.. (2004). A phase I/II study of gemcitabine and fractionated cisplatin in an outpatient setting using a 21-day schedule in patients with advanced and metastatic bladder cancer. British Journal of Cancer. 91(5). 844–849. 80 indexed citations
18.
Hussain, Syed A., Deborah Stocken, D. Peake, et al.. (2004). Long-term results of a phase II study of synchronous chemo radiotherapy in muscle invasive bladder cancer. Journal of Clinical Oncology. 22(14_suppl). 4585–4585. 1 indexed citations
19.
Hussain, Syed A., et al.. (2001). A phase I–II study of synchronous chemoradiotherapy for poor prognosis locally advanced bladder cancer. Annals of Oncology. 12(7). 929–935. 21 indexed citations
20.
Peake, D., et al.. (1999). Paget′s Osteosarcoma — no Cure in Sight. Sarcoma. 3(3-4). 191–192. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026